Ovarian Assessment – the Ovarian Assessment is a combination of a blood test and an ovarian scan
Follicles (which contain eggs) develop continuously on a “conveyor belt” system, but only 1 normally reaches maturity. Fertility drugs increase the number of eggs attaining maturity. The hormone AMH (Anti-Mullerian Hormone) is produced by the follicles at their early stages of development. In young women, the AMH is usually high because lots of follicles begin the maturation process In older women, there are usually fewer eggs left in the ovaries and the AMH level will be lower. Effectively, the blood level of AMH can tell us how many follicles (eggs) will be available when the fertility drugs are given. The normal population shows a considerable variation in AMH values and this is reflected in the wide range of responses to fertility drugs. The AMH level guides us on the appropriate dose of drugs and is an indicator of the chances of successful treatment.
The AMH test remains specialised and we ask that it is tested at GCRM-BELFAST, to ensure that the test has been carried out in the right manner.
A detailed pelvic scan will be performed at your consultation appointment. This will also assess the ovarian reserve and exclude any abnormalities that may interfere with your treatment.
We may ask for a semen sample for analysis even if you have had a recent test elsewhere as male fertility can change. Therefore, it is important to accurately assess your current fertility.
The laboratory staff will be analysing the:
- Count: how many sperm are present
- Motility: how many sperm are moving, and how quickly
- Morphology: how many sperm are of normal shape and size
We prefer you to produce the sample on site at GCRM-BELFAST and we have a room solely for this purpose. Ideally you should abstain from ejaculation for a minimum of 3 days but no more than 5 days (a shorter or longer period of abstinence can influence the quality of the sample).